中外製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/08/20 | 4,806 | 4,885 | 4,790 | 4,862 | +32 | +0.7% | 1,637,200 |
2020/08/19 | 4,890 | 4,919 | 4,820 | 4,830 | -43 | -0.9% | 1,256,200 |
2020/08/18 | 4,870 | 4,915 | 4,830 | 4,873 | +63 | +1.3% | 1,759,600 |
2020/08/17 | 4,950 | 4,958 | 4,810 | 4,810 | -177 | -3.5% | 1,788,300 |
2020/08/14 | 4,976 | 5,020 | 4,951 | 4,987 | +48 | +1% | 2,321,700 |
2020/08/13 | 4,880 | 4,957 | 4,810 | 4,939 | +138 | +2.9% | 2,420,700 |
2020/08/12 | 4,835 | 4,835 | 4,740 | 4,801 | -49 | -1% | 1,613,300 |
2020/08/11 | 4,751 | 4,882 | 4,710 | 4,850 | +26 | +0.5% | 2,373,900 |
2020/08/07 | 4,919 | 4,935 | 4,777 | 4,824 | -40 | -0.8% | 1,425,800 |
2020/08/06 | 4,910 | 4,930 | 4,845 | 4,864 | -62 | -1.3% | 1,133,600 |
2020/08/05 | 4,983 | 4,983 | 4,875 | 4,926 | +13 | +0.3% | 1,516,800 |
2020/08/04 | 4,944 | 5,008 | 4,908 | 4,913 | +10 | +0.2% | 2,221,800 |
2020/08/03 | 4,800 | 4,910 | 4,771 | 4,903 | +167 | +3.5% | 2,558,900 |
2020/07/31 | 4,896 | 4,899 | 4,734 | 4,736 | -232 | -4.7% | 3,131,400 |
2020/07/30 | 4,977 | 5,013 | 4,777 | 4,968 | -29 | -0.6% | 4,133,600 |
2020/07/29 | 5,011 | 5,279 | 4,821 | 4,997 | -41 | -0.8% | 5,683,300 |
2020/07/28 | 5,210 | 5,215 | 5,016 | 5,038 | -57 | -1.1% | 3,117,100 |
2020/07/27 | 5,097 | 5,164 | 5,066 | 5,095 | -102 | -2% | 2,322,500 |
2020/07/22 | 5,200 | 5,230 | 5,111 | 5,197 | -88 | -1.7% | 1,640,300 |
2020/07/21 | 5,233 | 5,315 | 5,222 | 5,285 | +105 | +2% | 2,011,400 |
2020/07/20 | 5,299 | 5,358 | 5,133 | 5,180 | -84 | -1.6% | 2,047,100 |
2020/07/17 | 5,237 | 5,294 | 5,195 | 5,264 | +72 | +1.4% | 1,692,700 |
2020/07/16 | 5,180 | 5,323 | 5,101 | 5,192 | -232 | -4.3% | 3,232,200 |
2020/07/15 | 5,293 | 5,478 | 5,254 | 5,424 | +130 | +2.5% | 2,252,200 |
2020/07/14 | 5,300 | 5,412 | 5,233 | 5,294 | -106 | -2% | 2,032,400 |
2020/07/13 | 5,400 | 5,436 | 5,283 | 5,400 | +2 | ±0% | 2,653,400 |
2020/07/10 | 5,547 | 5,596 | 5,398 | 5,398 | -122 | -2.2% | 3,028,500 |
2020/07/09 | 5,451 | 5,549 | 5,400 | 5,520 | -13 | -0.2% | 2,166,700 |
2020/07/08 | 5,475 | 5,629 | 5,447 | 5,533 | +43 | +0.8% | 2,997,000 |
2020/07/07 | 5,600 | 5,620 | 5,445 | 5,490 | -195 | -3.4% | 2,823,600 |
2020/07/06 | 5,745 | 5,751 | 5,625 | 5,685 | -64 | -1.1% | 1,633,700 |
2020/07/03 | 5,688 | 5,759 | 5,632 | 5,749 | +61 | +1.1% | 1,226,100 |
2020/07/02 | 5,781 | 5,820 | 5,572 | 5,688 | -42 | -0.7% | 2,018,200 |
2020/07/01 | 5,765 | 5,845 | 5,708 | 5,730 | -35 | -0.6% | 1,530,800 |
2020/06/30 | 5,876 | 5,897 | 5,654 | 5,765 | -56 | -1% | 2,648,800 |
2020/06/29 | 5,817 | 5,963 | 5,776 | 5,821 | -11,644 | -66.7% | 2,133,000 |
2020/06/26 | 17,505 | 17,575 | 17,370 | 17,465 | +35 | +0.2% | 570,200 |
2020/06/25 | 17,180 | 17,580 | 17,105 | 17,430 | +250 | +1.5% | 779,900 |
2020/06/24 | 16,910 | 17,370 | 16,865 | 17,180 | -60 | -0.3% | 747,500 |
2020/06/23 | 17,375 | 17,390 | 16,875 | 17,240 | -80 | -0.5% | 905,900 |
2020/06/22 | 16,780 | 17,480 | 16,765 | 17,320 | +545 | +3.2% | 756,600 |
2020/06/19 | 16,705 | 16,805 | 16,555 | 16,775 | +15 | +0.1% | 826,400 |
2020/06/18 | 16,895 | 16,945 | 16,660 | 16,760 | +165 | +1% | 640,200 |
2020/06/17 | 16,850 | 16,900 | 16,535 | 16,595 | -255 | -1.5% | 852,500 |
2020/06/16 | 16,390 | 16,880 | 16,155 | 16,850 | +850 | +5.3% | 1,198,500 |
2020/06/15 | 15,905 | 16,465 | 15,895 | 16,000 | -245 | -1.5% | 891,500 |
2020/06/12 | 15,895 | 16,545 | 15,690 | 16,245 | +390 | +2.5% | 1,634,000 |
2020/06/11 | 16,005 | 16,050 | 15,840 | 15,855 | +45 | +0.3% | 1,024,300 |
2020/06/10 | 15,450 | 15,850 | 15,385 | 15,810 | +425 | +2.8% | 894,800 |
2020/06/09 | 15,320 | 15,645 | 15,230 | 15,385 | -295 | -1.9% | 1,429,100 |
1151~
1200
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
中外薬 | 862,000円 | +1.7% | +5.0% | 2.90% | 34.60倍 | 7.46倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
第一三共 | 370,200円 | +6.0% | +4.0% | 2.11% | 22.98倍 | 4.25倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
武 田 | 441,900円 | +7.7% | +206.9% | 4.44% | 59.10倍 | 1.00倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 769,700円 | +2.2% | +10.2% | 1.56% | 14.78倍 | 1.49倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム